Cyclo therapeutics provides business update and reports second quarter 2021 financial results

Gainesville, fla.--(business wire)--cyclo therapeutics, inc. (nasdaq: cyth) (“cyclo therapeutics” or the “company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the second quarter of 2021, and provided a business update. “our second quarter was marked by solid execution across multiple fronts. on the heels on positive topline results
CYTH Ratings Summary
CYTH Quant Ranking